Cognition Studio, Inc.

Telios Pharma - TL-895 MOA at EHA 2023 

Prev Next
Previous

Kartos Therapeutics - Navtemadlin MOA at EHA 2023

Next medical animation of TriSalus takes an integrated approach tailored to the target organ and disease biology to overcome two critical barriers: immunosuppression and delivery. This composite video tells the complexity of TriSalus' story by communicating the value of SD-101, a therapeutic that delivers organ-specific immunomodulation, and SmartValve™ technology, a regional intravascular, Pressure-Enabled Drug Delivery approach to increase therapeutic value and support better patient outcomes.

TriSalus: SD-101 and SmartValve Technology

This MOA was one of four videos displayed on the side of a 13-foot, 30,000-pound Cube exhibited at the 2023 European Hematological Association's (EHA) conference in Frankfurt, Germany. For scale, the video's round viewing portal was ~10 feet tall and displayed via an LED wall.

Keywords: Animation, Color, 3D, Video, Advertising / Marketing, Biotechnology, Cell biology / Histology, Molecular Biology, Oncology, Mechanism of Action (MOA)

Telios Pharma